Salmeterol Xinafoate API: Micronized Inhalation & injectable Grades

Salmeterol Xinafoate API: Micronized Inhalation & injectable Grades

Salmeterol Xinafoate API: Micronized Inhalation & injectable Grades

Salmeterol Xinafoate is a highly lipophilic, long-acting beta-2 adrenergic receptor agonist (LABA). Unlike short-acting bronchodilators, its long aliphatic side chain anchors it to the receptor, providing sustained bronchodilation for over 12 hours. It is an essential active ingredient for the maintenance treatment of nocturnal asthma, exercise-induced bronchospasm, and COPD.

At Micro Orgo Chem (MOC), we excel in the complex particle engineering required for respiratory drugs. Our GMP certified facility utilizes specialized air-jet micronization to achieve a Particle Size Distribution (PSD) of D90 < 5µm, ensuring optimal lung deposition for MDI and DPI devices. We also offer a validated injectable Grade processed under strict aseptic conditions for advanced research and specialized delivery systems.

Our API is compliant with USP, EP (Ph. Eur.), and IP pharmacopeias, maintaining absolute polymorphic stability and ultra-low impurity profiles.

Salmeterol Xinafoate Identification Data

Product Salmeterol Xinafoate
CAS Number 94749-08-3
MF C36H45NO7
MW 603.74
Melting Point Refer To COA

Global Supply Chain Resilience

Salmeterol Xinafoate is a critical component of Fixed-Dose Combination (FDC) therapies. Micro Orgo Chem ensures batch-to-batch consistency and absolute lead-time security through integrated manufacturing at our Vapi works. Our expertise in Particle Size Distribution (PSD) engineering ensures that your inhalation formulations maintain consistent dose delivery, shielding your product from technical and regulatory volatility.

Our Clients

For bulk procurement or technical specifications, contact our sales team.